Trial Profile
Retrospective study of zonisamide and istradefylline in treating patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2018
Price :
$35
*
At a glance
- Drugs Istradefylline (Primary) ; Zonisamide (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 28 Nov 2018 New trial record
- 09 Oct 2018 Results presented at the 22nd International Congress of Parkinson's Disease and Movement Disorders